Analona Therapeutics

Analona Therapeutics is a newly founded (2024) Danish biotech company focused on discovering and developing novel antibody-based therapeutics for solid tumors. The company leverages proprietary research to identify novel targets and mechanisms of action, with an initial program targeting a key interactor and facilitator of metabolite transporters. Its mission is to revolutionize solid tumor treatment through first-in-class, tumor-specific metabolic disruptors.